The DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
Open accessAbstract
Metabolic dysfunction–associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), is a growing but often unrecognized medical problem for people with diabetes (particularly type 2 diabetes, especially when associated with obesity). Liver health has not been at the forefront of complications tracked for disease prevention, as traditionally done for diabetic retinopathy, nephropathy, or neuropathy. However, liver steatosis affects approximately two out of three people with type 2 diabetes and places them at an increased risk for metabolic dysfunction–associated steatohepatitis (MASH), cirrhosis, hepatocellular carcinoma (HCC), and overall liver-related mortality. MASLD is also associated with extrahepatic cancers, atherosclerotic cardiovascular disease, and progression from prediabetes to type 2 diabetes and negatively impacts health-related quality of life. However, most individuals and their health care professionals remain unaware of the severe hepatic or extrahepatic health risks associated with MASLD and the need for early identification. In recognition of this knowledge gap and the rising prevalence of MASLD, this consensus report is a call to action to screen for liver fibrosis and risk stratify people with prediabetes or type 2 diabetes, in particular if obesity is also present. This consensus report explains the rationale for the recent MASLD nomenclature change, how to best risk stratify, current treatment and long-term monitoring options, the value of an interprofessional approach to disease management, and the impact of alcohol intake on liver health. More awareness about the health risks associated with MASLD and broad adoption of screening for liver fibrosis as a new standard of care hold promise for a future without cirrhosis for people with prediabetes and type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–265 of 265
Lawitz, E., Fraessdorf, M., Neff, G. W., Schattenberg, J. M., Noureddin, M., Alkhouri, N., Schmid, B., Andrews, C. P., Takács, I., Hussain, S. A., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.06.003 · Cited by 65
Self-citationDiabetes as a risk factor for MASH progression
Gancheva, S., Roden, M., & Castéra, L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111846 · Cited by 65
Self-citation(2021) · doi:10.1007/s12072-021-10242-2 · Cited by 64
Carrieri, P., Mourad, A., Marcellin, F., Trylesinski, A., Calleja, J. L., Protopopescu, C., & Lazarus, J. V. (2022) · Liver International · doi:10.1111/liv.15209 · Cited by 62
Ciardullo, S., & Perseghin, G. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109981 · Cited by 62
Metabolic syndrome traits increase the risk of major adverse liver outcomes in type 2 diabetes
Shang, Y., Grip, E. T., Modica, A., Skröder, H., Ström, O., Ntanios, F., Gudbjörnsdottir, S., & Hagström, H. (2024) · Diabetes Care · doi:10.2337/dc23-1937 · Cited by 61
Heba, E. R., Desai, A. S., Zand, K. A., Hamilton, G., Wolfson, T. J., Schlein, A. N., Gamst, A. C., Loomba, R. S., Sirlin, C. B., & Middleton, M. S. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25006 · Cited by 61
High prevalence of diabetes mellitus in patients with liver cirrhosis
Wlazlo, N., Beijers, H. J. B. H., Schoon, E. J., Sauerwein, H. P., Stehouwer, C. D. A., & Bravenboer, B. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03093.x · Cited by 60
Ferdous, S.-E., & Ferrell, J. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168731 · Cited by 60
Tuo, S., Yeo, Y. H., Chang, R., Zhang, W., Ran, Q., Yang, L., Fan, Q., Kang, J., Si, J., Liu, Y., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.11.008 · Cited by 59
Joint association of glycemic load and alcohol intake with type 2 diabetes incidence in women
Mekary, R. A., Rimm, E. B., Giovannucci, E. L., Stampfer, M. J., Willett, W. C., Ludwig, D. S., & Hu, F. B. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.023754 · Cited by 58
Zhang, X., Yip, T. C.-F., Wong, G. L.-H., Leow, W.-X., Liang, L. Y., Lim, L.-L., Li, G., Ibrahim, L., Lin, H., Lai, J. C. T., et al. (2023) · Gut · doi:10.1136/gutjnl-2023-330269 · Cited by 55
Honda, F., Hiramatsu, A., Hyogo, H., Aikata, H., Daijo, K., Teraoka, Y., Inagaki, Y., Morio, K., Kobayashi, T., Nakahara, T., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195028 · Cited by 54
Kawamori, R., Kadowaki, T., Onji, M., Seino, Y., & Akanuma, Y. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.08.017 · Cited by 53
DeFronzo, R. A., CHILTON, R. J., Norton, L., Clarke, G., Ryder, R. E. J., & Abdul‐Ghani, M. A. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12652 · Cited by 53
Costa, D., Lourenço, J., Monteiro, A. M., Castro, B., Oliveira, P., Tinoco, M. C., Fernandes, V., Marques, O., Gonçalves, R., & Rolanda, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-64141-x · Cited by 53
Cuthbertson, D. J., Koskinen, J. M., Brown, E. E., Magnussen, C. G., Hutri‐Kähönen, N., Sabin, M. A., Tossavainen, P. H., Jokinen, E. V., Laitinen, T. P., Viikari, J. S. A., et al. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1956685 · Cited by 53
Enhanced liver fibrosis (ELF) score predicts hepatic decompensation and mortality
Pearson, M., Nobes, J. H., MacPherson, I. S., Gold, L., Miller, M. J., Dow, E., & Dillon, J. F. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101062 · Cited by 53
Preparing for the NASH epidemic: A call to action
Kanwal, F., Shubrook, J. H., Younossi, Z. M., Natarajan, Y., Bugianesi, E., Rinella, M. E., Harrison, S. A., Mantzoros, C. S., Pfotenhauer, K. M., Klein, S., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154822 · Cited by 52
Self-citationStine, J. G., Long, M. T., Corey, K. E., Sallis, R. E., Allen, A. M., Armstrong, M. J., Conroy, D. E., Cuthbertson, D. J., Duarte‐Rojo, A., Hallsworth, K., et al. (2023) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003199 · Cited by 51
Nam, H., Yoo, J., Cho, Y., Kang, S. H., Ahn, S. B., Lee, H. W., Jun, D. W., Song, D. S., & Choi, M. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.12.013 · Cited by 46
Guan, L., Li, L., Zou, Y., Zhong, J., & Qiu, L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1172178 · Cited by 46
Lavynenko, O., Abdul‐Ghani, M., Alatrach, M., Puckett, C., Adams, J., Abdelgani, S., Alkhouri, N., Triplitt, C., Clarke, G. D., Vasquez, J. A., et al. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14650 · Cited by 44
Yoneda, M., Kobayashi, T., Honda, Y., Ogawa, Y., Kessoku, T., Imajo, K., Nogami, A., Taguri, M., Kirikoshi, H., Saito, S., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1993 · Cited by 43
Practical Lifestyle Management of Nonalcoholic Fatty Liver Disease for Busy Clinicians
Zelber‐Sagi, S., & Moore, J. B. (2024) · Diabetes Spectrum · doi:10.2337/dsi23-0009 · Cited by 43
Cusi, K. J., Sanyal, A. J., Zhang, S., Hoogwerf, B. J., Chang, A. M., Jacober, S. J., Bue-Valleskey, J. M., Higdon, A. N., Bastyr, E. J., Haupt, A., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12751 · Cited by 41
Self-citationAgarwal, L., Sahu, A. K., Baksi, A., Agarwal, A., & Aggarwal, S. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.11.004 · Cited by 41
Udompap, P., Therneau, T. M., Canning, R. E., Benson, J. T., & Allen, A. M. (2023) · Hepatology · doi:10.1002/hep.32739 · Cited by 37
Recompensation in MASLD-related cirrhosis via metabolic bariatric surgery
Feng, G., Han, Y., Yang, W., Shikora, S. A., Mahawar, K. K., Cheung, T. T., Targher, G., Byrne, C. D., Hernández–Gea, V., Tilg, H., et al. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.05.009 · Cited by 36
Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease
Stepanova, M., Henry, L. L., & Younossi, Z. M. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.01.007 · Cited by 35
Self-citationMurata, C., Suzuki, Y., Muramatsu, T., Taniyama, M., Atsumi, Y., Matsuoka, K., Watanabe, T., & Okazaki, I. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb00003.x · Cited by 33
From NAFLD to MASLD: Promise and pitfalls of a new definition†
Cusi, K. J., Younossi, Z. M., & Roden, M. (2023) · Hepatology · doi:10.1097/hep.0000000000000706 · Cited by 33
Self-citationRacial and ethnic disparities in non-alcoholic fatty liver disease in the USA
Rich, N. E., Noureddin, M., Kanwal, F., & Singal, A. G. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00100-x · Cited by 32
Self-citationKamada, Y., Munekage, K., Nakahara, T., Fujii, H., Sawai, Y., Doi, Y., Hyogo, H., Sumida, Y., Imai, Y., Miyoshi, E., et al. (2022) · Nutrients · doi:10.3390/nu15010066 · Cited by 32
Accurate measurement of total and free testosterone levels for the diagnosis of androgen disorders
Guzelce, E. C., Galbiati, F., Goldman, A. L., Gattu, A. K., Basaria, S. S., & Bhasin, S. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101683 · Cited by 30
Arai, T., Takahashi, K., Seko, Y., Toyoda, H., Hayashi, H., Yamaguchi, K., Iwaki, M., Yoneda, M., Shima, T., Fujii, H., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.11.022 · Cited by 30
Nonalcoholic Fatty Liver Disease in Diabetes: A Call to Action
Cusi, K. J. (2024) · Diabetes Spectrum · doi:10.2337/dsi23-0015 · Cited by 29
Self-citationSevere hypoglycemia in patients with liver cirrhosis and type 2 diabetes
Yen, F., Hou, M., Liu, J., Hsu, C., & Hwu, C. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.962337 · Cited by 27
Lee, J., Kim, Y., Han, K., Han, E., Lee, B., Kang, E. S., Soo, B., Ko, S., & Lee, Y. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.0262 · Cited by 26
Noureddin, N., Ajmera, V. H., Bergstrom, J., Bettencourt, R., Huang, D. Q., Siddiqi, H., Majzoub, A. M., Nayfeh, T., Tamaki, N., Izumi, N., et al. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17707 · Cited by 26
Anson, M., Henney, A. E., Zhao, S. S., Hernández, G., Lip, G. Y. H., Cuthbertson, D. J., Nabrdalik, K., & Alam, U. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15576 · Cited by 25
Norwood, P., Liutkus, J. F., Haber, H., Pintilei, E., Boardman, M. K., & Trautmann, M. E. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.09.007 · Cited by 24
Exercise as an intervention for patients with end-stage liver disease: Systematic review
Locklear, C. T., Golabi, P., Gerber, L. H., & Younossi, Z. M. (2018) · Medicine · doi:10.1097/md.0000000000012774 · Cited by 24
Self-citationBanini, B. A., Cazanave, S. C., Yates, K. P., Asgharpour, A., Vincent, R. J., Mirshahi, F., Le, P., Contos, M. J., Tonascia, J. A., Chalasani, N., et al. (2018) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001142 · Cited by 24
Self-citationSanyal, A. J., Muñoz, B., Cusi, K. J., Barritt, A. S., Muthiah, M. D., Mospan, A. R., Reddy, K. R., Firpi-Morell, R. J., Thuluvath, P. J., Bhamidimarri, K. R., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.02.024 · Cited by 24
Self-citationAgabio, R., Madeddu, C., Contu, P., Cosentino, S., Deiana, M., Massa, E., Mereu, A., Politi, C., Sardu, C., & Sinclair, J. (2021) · Alcohol and Alcoholism · doi:10.1093/alcalc/agab042 · Cited by 23
Behavioral weight-loss interventions for patients with NAFLD: A systematic scoping review
Balakrishnan, M., Liu, K., Schmitt, S., Heredia, N. I., Sisson, A., Montealegre, J. R., Hernáez, R., Kanwal, F., & Foreyt, J. P. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000224 · Cited by 23
Self-citationSharma, A. R., Leiva, E. G., Kalavalapalli, S., Lomonaco, R., MARANGI, S. A., SAENZ, E. V., Gonzalez, M. A., Rocha, A. O., CUERVO-PARDO, N., Rosenberg, J. T., et al. (2024) · Obesity · doi:10.1002/oby.24130 · Cited by 23
Self-citationAttaran, F., Emami, S., Sohrabi, M., Malek, M., Ajdarkosh, H., Khoonsari, M., Ismail-Beigi, F., & Khamseh, M. E. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02948-4 · Cited by 22
Alcohol and the risk of colon and rectal cancer with mutations in the K-ras gene
Bongaerts, B. W. C., de Goeij, A. F. P. M., van den Brandt, P. A., & Weijenberg, M. P. (2006) · Alcohol · doi:10.1016/j.alcohol.2006.06.003 · Cited by 22
Cusi, K. J., Budd, J., Johnson, E. L., & Shubrook, J. H. (2024) · Diabetes Spectrum · doi:10.2337/dsi23-0014 · Cited by 22
Self-citationWeight Gain and Glycemic Control in Adults with Type 1 Diabetes in the T1D Exchange Registry
Bailey, R., Calhoun, P., & Garg, S. K. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0389 · Cited by 21
Abdul‐Ghani, M., Migahid, O., Megahed, A., DeFronzo, R. A., Al‐Ozairi, E., & Jayyousi, A. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14153 · Cited by 21
Duman, S., Kuru, D., Gümüşsoy, M., Kiremitçi, S., Gökcan, H., Ulas, B., Ellik, Z. M., Özercan, M., Er, R. E., Karakaya, F., et al. (2023) · European Radiology · doi:10.1007/s00330-023-10441-5 · Cited by 20
Stepanova, M., Kumar, A. R., Brandt, P., Gundurao, N., Cusi, K. J., Qahtani, S. A., & Younossi, Z. M. (2023) · Diabetes Care · doi:10.2337/dc23-1085 · Cited by 19
Self-citationChhabra, S., Singh, S., Singh, A., Mehta, V., Kaur, A., Bansal, N., & Sood, A. (2021) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2021.07.001 · Cited by 18
Lombardi, R., Mantovani, A., Cespiati, A., Francione, P., Maffi, G., Zanna, E. D., Maffeis, C., Colecchia, A., Passigato, N., Ferrarese, A., et al. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.09.023 · Cited by 17
Ye, Q., Ouyang, X., Qin, Z., Chen, Y., Zhang, X., Liu, Y., Lou, Q., & Xu, F. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14108 · Cited by 17
Khanmohammadi, S., Habibzadeh, A., Kamrul-Hasan, A. B. M., Schuermans, A., & Kuchay, M. S. (2024) · Diabetic Medicine · doi:10.1111/dme.15437 · Cited by 17
Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease in Endocrinology Clinics
Younossi, Z. M., Henry, L. L., Isaacs, S. D., & Cusi, K. J. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.06.012 · Cited by 15
Self-citationSanyal, A. J., Magnanensi, J., Majd, Z., Rosenquist, C., Vera, D. M., Almas, J. P., & Connelly, M. A. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000223 · Cited by 12
Self-citationLafarge, J.-C., Aron‐Wisnewsky, J., Pattou, F. N., Cucherat, M., Blondet, E., Lascols, S., Guludec, D. L., David, D.-J., & Carbonneil, C. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101495 · Cited by 12
Diabetes and the risk of cirrhosis and HCC: An analysis of the UK Biobank
Ye, F., Chen, L., & Zheng, X. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000280 · Cited by 10
Obeso-Fernández, J., Millán-Alanís, J. M., Sáenz-Flores, M., Rodríguez-Bautista, M., Medrano-Juárez, S., Oyervides-Fuentes, S., Gonzalez‐Cruz, D., Manzanares-Gallegos, D. M., González‐González, J. G., & Rodríguez-Gutiérrez, R. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2023.08.016 · Cited by 9
Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis
Kahl, S., Pützer, J., & Roden, M. (2022) · Seminars in Liver Disease · doi:10.1055/s-0041-1732354 · Cited by 5
Self-citation
Metadata
- Authors
- Cusi, K., Abdelmalek, M. F., Apovian, C. M., Balapattabi, K., Bannuru, R. R., Barb, D., Bardsley, J. K., Beverly, E. A., Corbin, K. D., ElSayed, N. A., Isaacs, S., Kanwal, F., Pekas, E. J., Richardson, C. R., Roden, M., Sanyal, A. J., Shubrook, J. H., Younossi, Z. M., & Bajaj, M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2025-05-28
- Volume
- 48
- Issue
- 7
- Pages
- 1057-1082
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4410823798
- Cited by
- 332
- References
- 265
- FWCI
- 203.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.